Загрузка...
Pazopanib in the treatment of advanced renal cell carcinoma
Pazopanib is an orally available multitargeted tyrosine kinase inhibitor (a class of targeted therapies) that inhibits tumor angiogenesis and cell proliferation. The safety and efficacy of pazopanib (noninferior to sunitinib for progression-free survival) in patients with advanced or metastatic rena...
Сохранить в:
| Опубликовано в: : | Ther Adv Urol |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4707425/ https://ncbi.nlm.nih.gov/pubmed/26834841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287215614236 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|